The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial
Open accessAbstract
OBJECTIVE: To determine whether screening and treating women for chlamydial infection reduces the incidence of pelvic inflammatory disease over the subsequent 12 months. DESIGN: Randomised controlled trial. SETTING: Common rooms, lecture theatres, and student bars at universities and further education colleges in London. PARTICIPANTS: 2529 sexually active female students, mean age 21 years (range 16-27). INTERVENTION: Participants completed a questionnaire and provided self taken vaginal swabs, with follow-up after one year. Samples were randomly allocated to immediate testing and treatment for chlamydial infection, or storage and analysis after a year (deferred screening controls). MAIN OUTCOME MEASURE: Incidence of clinical pelvic inflammatory disease over 12 months. RESULTS: Baseline prevalence of chlamydia was 5.4% (68/1254) in screened women and 5.9% (75/1265) in controls. 94% (2377/2529) of women were followed up after 12 months. The incidence of pelvic inflammatory disease was 1.3% (15/1191) in screened women compared with 1.9% (23/1186) in controls (relative risk 0.65, 95% confidence interval 0.34 to 1.22). Seven of 74 control women (9.5%, 95% confidence interval 4.7% to 18.3%) who tested positive for chlamydial infection at baseline developed pelvic inflammatory disease over 12 months compared with one of 63 (1.6%) screened women (relative risk 0.17, 0.03 to 1.01). However, most episodes of pelvic inflammatory disease occurred in women who tested negative for chlamydia at baseline (79%, 30/38). 22% (527/2377) of women reported being tested independently for chlamydia during the trial. CONCLUSION: Although some evidence suggests that screening for chlamydia reduces rates of pelvic inflammatory disease, especially in women with chlamydial infection at baseline, the effectiveness of a single chlamydia test in preventing pelvic inflammatory disease over 12 months may have been overestimated. Trial registration ClinicalTrials.gov NCT00115388.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,331
Sexually Transmitted Diseases Treatment Guidelines, 2006
Skolnik, N. S. (2007) · Current Clinical Practice · doi:10.1007/978-1-59745-313-4_17 · Cited by 3,124
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Comparative analysis of two rates
Miettinen, O., & Nurminen, M. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040211 · Cited by 1,110
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection
Scholes, D., Stergachis, A., Heidrich, F. E., Andrilla, H., Holmes, K. K., & Stamm, W. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342103 · Cited by 847
Ness, R. B., Soper, D. E., Holley, R. L., Peipert, J., Randall, H., Sweet, R. L., Sondheimer, S. J., Hendrix, S. L., Amortegui, A., Trucco, G., et al. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.121625 · Cited by 414
Schachter, J., Chernesky, M. A., Willis, D. E., Fine, P. M., Martin, D. H., Fuller, D., Jordan, J. A., Janda, W., & Hook, E. W. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000190092.59482.96 · Cited by 253
Criteria for diagnosis and grading of salpingitis.
Hager, W. D., Eschenbach, D. A., Spence, M., & Sweet, R. L. (1983) · PubMed · Cited by 201
Østergaard, L., Andersen, B., Møller, J. K., & Olesen, F. (2000) · Clinical Infectious Diseases · doi:10.1086/318139 · Cited by 179
Bacterial vaginosis and risk of pelvic inflammatory disease.
Ness, R. B., Hillier, S. L., Kip, K. E., Soper, D. E., Stamm, C. A., McGregor, J. A., Bass, D. C., Sweet, R. L., Rice, P., & Richter, H. E. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000139512.37582.17 · Cited by 169
Low, N. (2006) · Sexually Transmitted Infections · doi:10.1136/sti.2005.017186 · Cited by 159
Effectiveness of chlamydia screening: systematic review
Low, N. N., Bender, N., Nartey, L., Shang, A., & Stephenson, J. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn222 · Cited by 132
Oakeshott, P., Hay, P., Hay, S., Steinke, F., Rink, E., & Kerry, S. (2002) · BMJ · doi:10.1136/bmj.325.7376.1334 · Cited by 121
Self-citationThe cost effectiveness of opportunistic chlamydia screening in England
Adams, E. J., Turner, K., Edmunds, W. J., Roberts, T. E., Low, N. N., Adams, E. J., Edmunds, W. J., & Turner, K. (2007) · Sexually Transmitted Infections · doi:10.1136/sti.2006.024364 · Cited by 87
Simms, I., ROGERS, P. A., & Charlett, A. (1999) · International Journal of STD & AIDS · doi:10.1258/0956462991914447 · Cited by 60
Self-citationBacterial Vaginosis and Risk of Pelvic Inflammatory Disease
Ness, R. B., Hillier, S. L., Kip, K. E., Soper, D. E., Stamm, C. A., McGregor, J., Bass, D. C., Sweet, R. L., Rice, P. A., & Richter, H. E. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000151758.26985.ed · Cited by 29
Oakeshott, P., Kerry, S., Atherton, H., Aghaizu, A., Hay, S., TAYLOR‐ROBINSON, D., Simms, I., & Hay, P. (2008) · Trials · doi:10.1186/1745-6215-9-73 · Cited by 26
Self-citationCommentary: Chlamydia trachomatis screening: what are we trying to do?
Peterman, T. A., Gottlieb, S. L., & Berman, S. M. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn345 · Cited by 17
Has the incidence of pelvic inflammatory disease following chlamydial infection been overestimated?
Simms, I., & Horner, P. (2008) · International Journal of STD & AIDS · doi:10.1258/ijsa.2007.007316 · Cited by 15
Self-citationIvaz, S. L., Brennan, S., Dean, S., Hay, S., Hay, P., Kerry, S., & Oakeshott, P. (2006) · Family Practice · doi:10.1093/fampra/cmi109 · Cited by 14
Self-citationRecruitment of young women to a trial of chlamydia screening – as easy as it sounds?
Atherton, H., Banks, D., Harbit, R., Long, L., Chadd, F., Hay, P., Kerry, S., Simms, I., & Oakeshott, P. (2007) · Trials · doi:10.1186/1745-6215-8-41 · Cited by 12
Self-citationScreening for chlamydia to prevent pelvic inflammatory disease.
Pérez, J. J. V., Arsura, E. L., & Abraham, J. J. (1996) · PubMed · Cited by 10
Screening for Chlamydia to Prevent Pelvic Inflammatory Disease
Abter, E. I., & Mahmud, M. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611143352012 · Cited by 4
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Sexually Transmitted Diseases Treatment Guidelines, 2010
(2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,076
Sexually transmitted infections: challenges ahead
Unemo, M., Bradshaw, C. S., Hocking, J. S., de Vries, H. J. C., Francis, S. C., Mabey, D., Marrazzo, J. M., Sonder, G. J. B., Schwebke, J. R., Hoornenborg, E., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30310-9 · Cited by 751
Brunham, R. C., Gottlieb, S. L., & Paavonen, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1411426 · Cited by 739
Risk of Sequelae after Chlamydia trachomatis Genital Infection in Women
Haggerty, C. L., Gottlieb, S. L., Taylor, B. D., Low, N., Xu, F., & Ness, R. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/652395 · Cited by 657
Metadata
- Authors
- Oakeshott, P., Kerry, S., Aghaizu, A., Atherton, H., Hay, S., Taylor-Robinson, D., Simms, I., & Hay, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2010-04-08
- Volume
- 340
- Issue
- apr08 1
- Pages
- c1642-c1642
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2100223549
- Cited by
- 340
- References
- 23
- FWCI
- 27.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.